Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/213308 |
Resumo: | Objective: Therapeutic targets in Idiopathic Inflammatory Myopathies (IIM) are based on the opinions of physicians/specialists, which may not reflect the main concerns of patients. The authors, therefore, assessed the outcome concerns of patients with IIM and compared them with the concerns of rheumatologists in order to develop an IIM outcome standard set. Methods: Ninety-three IIM patients, 51 rheumatologists, and one physiotherapist were invited to participate. An open questionnaire was initially applied. The top 10 answers were selected and applied in a multiple-choice questionnaire, inquiring about the top 3 major concerns. Answers were compared, and the agreement rate was calculated. Concerns were gathered in an IIM outcome standard set with validated measures. Results: The top three outcome concerns raised by patients were medication side effects/muscle weakness/prevention functionality loss. The top three concerns among rheumatologists were to prevent loss of functionality/to ensure the quality of life/to achieve disease remission. Other's outcomes concerns only pointed out by patients were muscle pain/diffuse pain/skin lesions/fatigue. The agreement rate between both groups was 41%. Assessment of these parameters guided the development of an IIM standard set which included Myositis Disease Activity Assessment Visual Analogue Scale/Manual Muscle Testing/fatigue and pain Global Visual Analogue Scale/Health Assessment Questionnaire/level of physical activity. Conclusion: The authors propose a novel standard set to be pursued in IIM routine follow-up, which includes not only the main patients/rheumatologist outcome concerns but also additional important outcomes only indicated by patients. Future studies are necessary to confirm if this comprehensive approach will result in improved adherence and ultimately in better assistance. |
id |
USP-19_98f6eb9fa8d090070598842331dfc22a |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/213308 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathiesIdiopathic inflammatory myopathiesPatient reported outcome measureTreat to targetOutcome concernsObjective: Therapeutic targets in Idiopathic Inflammatory Myopathies (IIM) are based on the opinions of physicians/specialists, which may not reflect the main concerns of patients. The authors, therefore, assessed the outcome concerns of patients with IIM and compared them with the concerns of rheumatologists in order to develop an IIM outcome standard set. Methods: Ninety-three IIM patients, 51 rheumatologists, and one physiotherapist were invited to participate. An open questionnaire was initially applied. The top 10 answers were selected and applied in a multiple-choice questionnaire, inquiring about the top 3 major concerns. Answers were compared, and the agreement rate was calculated. Concerns were gathered in an IIM outcome standard set with validated measures. Results: The top three outcome concerns raised by patients were medication side effects/muscle weakness/prevention functionality loss. The top three concerns among rheumatologists were to prevent loss of functionality/to ensure the quality of life/to achieve disease remission. Other's outcomes concerns only pointed out by patients were muscle pain/diffuse pain/skin lesions/fatigue. The agreement rate between both groups was 41%. Assessment of these parameters guided the development of an IIM standard set which included Myositis Disease Activity Assessment Visual Analogue Scale/Manual Muscle Testing/fatigue and pain Global Visual Analogue Scale/Health Assessment Questionnaire/level of physical activity. Conclusion: The authors propose a novel standard set to be pursued in IIM routine follow-up, which includes not only the main patients/rheumatologist outcome concerns but also additional important outcomes only indicated by patients. Future studies are necessary to confirm if this comprehensive approach will result in improved adherence and ultimately in better assistance.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2022-04-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21330810.1016/j.clinsp.2022.100031Clinics; Vol. 77 (2022); 100031Clinics; v. 77 (2022); 100031Clinics; Vol. 77 (2022); 1000311980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/213308/195256Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessBertoglio, Isabela M.Abrahao, Glaucia F.Souza, Fernando H.C. deMiossi, RenataMoraes, Paloma C. deShinjo, Samuel K.Bonfá, EloisaLopes, Michelle R. Ugolini2023-07-06T13:04:56Zoai:revistas.usp.br:article/213308Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:04:56Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies |
title |
Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies |
spellingShingle |
Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies Bertoglio, Isabela M. Idiopathic inflammatory myopathies Patient reported outcome measure Treat to target Outcome concerns |
title_short |
Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies |
title_full |
Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies |
title_fullStr |
Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies |
title_full_unstemmed |
Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies |
title_sort |
Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies |
author |
Bertoglio, Isabela M. |
author_facet |
Bertoglio, Isabela M. Abrahao, Glaucia F. Souza, Fernando H.C. de Miossi, Renata Moraes, Paloma C. de Shinjo, Samuel K. Bonfá, Eloisa Lopes, Michelle R. Ugolini |
author_role |
author |
author2 |
Abrahao, Glaucia F. Souza, Fernando H.C. de Miossi, Renata Moraes, Paloma C. de Shinjo, Samuel K. Bonfá, Eloisa Lopes, Michelle R. Ugolini |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Bertoglio, Isabela M. Abrahao, Glaucia F. Souza, Fernando H.C. de Miossi, Renata Moraes, Paloma C. de Shinjo, Samuel K. Bonfá, Eloisa Lopes, Michelle R. Ugolini |
dc.subject.por.fl_str_mv |
Idiopathic inflammatory myopathies Patient reported outcome measure Treat to target Outcome concerns |
topic |
Idiopathic inflammatory myopathies Patient reported outcome measure Treat to target Outcome concerns |
description |
Objective: Therapeutic targets in Idiopathic Inflammatory Myopathies (IIM) are based on the opinions of physicians/specialists, which may not reflect the main concerns of patients. The authors, therefore, assessed the outcome concerns of patients with IIM and compared them with the concerns of rheumatologists in order to develop an IIM outcome standard set. Methods: Ninety-three IIM patients, 51 rheumatologists, and one physiotherapist were invited to participate. An open questionnaire was initially applied. The top 10 answers were selected and applied in a multiple-choice questionnaire, inquiring about the top 3 major concerns. Answers were compared, and the agreement rate was calculated. Concerns were gathered in an IIM outcome standard set with validated measures. Results: The top three outcome concerns raised by patients were medication side effects/muscle weakness/prevention functionality loss. The top three concerns among rheumatologists were to prevent loss of functionality/to ensure the quality of life/to achieve disease remission. Other's outcomes concerns only pointed out by patients were muscle pain/diffuse pain/skin lesions/fatigue. The agreement rate between both groups was 41%. Assessment of these parameters guided the development of an IIM standard set which included Myositis Disease Activity Assessment Visual Analogue Scale/Manual Muscle Testing/fatigue and pain Global Visual Analogue Scale/Health Assessment Questionnaire/level of physical activity. Conclusion: The authors propose a novel standard set to be pursued in IIM routine follow-up, which includes not only the main patients/rheumatologist outcome concerns but also additional important outcomes only indicated by patients. Future studies are necessary to confirm if this comprehensive approach will result in improved adherence and ultimately in better assistance. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-04-11 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/213308 10.1016/j.clinsp.2022.100031 |
url |
https://www.revistas.usp.br/clinics/article/view/213308 |
identifier_str_mv |
10.1016/j.clinsp.2022.100031 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/213308/195256 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 77 (2022); 100031 Clinics; v. 77 (2022); 100031 Clinics; Vol. 77 (2022); 100031 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222766588231680 |